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Microbial growth in moisture-damaged
buildings has been associated with adverse
health effects, such as frequent respiratory
infections, rhinitis, eye irritation, and
asthma (Brunekreef 1992; Koskinen et al.
1999; Pirhonen et al. 1996; Platt et al.
1989; Spengler et al. 1994; Strachan 1988;
Taskinen et al. 1997; Waegemaekers et al.
1989). Even serious effects, such as idiopathic
pulmonary hemorrhage in infants, have been
suspected to be caused by excessive microbial
growth in moisture-damaged buildings
(Dearborn et al. 1999; Flappan et al. 1999;
Hagmann 2000). Lungs represent a very
important route of microbial exposure in the
occupants of moisture-damaged buildings.
However, the responsible microbes and the
speciﬁc mechanisms of the effects on the res-
piratory tract leading to clinical symptoms are
still unknown. This is particularly true for
environmental mycobacteria growing in
moisture-damaged buildings.
Mycobacteria are present in the building
materials of moisture-damaged buildings
(Andersson et al. 1997), and they may
spread into the indoor air, especially during
demolition work. Mycobacterium terrae is an
environmental, slow-growing mycobacterium,
usually considered to be nonpathogenic to
humans (Goodfellow and Magee 1998;
Shimizu et al. 1999). However, some cases of
mycobacterial infections in lungs caused by
this microbe have been diagnosed among both
immunocompromised patients and patients
with normal immunologic  status (Krisher et
al. 1988; Kuze et al. 1983; Palmero et al.
1989; Peters and Morice 1991; Spence and
Ferris 1996). For example, M. terrae has pro-
voked lymphadenitis in a nonimmunocom-
promised host (Shimizu et al. 1999). We have
previously shown that M. terrae, isolated from
indoor air of a moisture-damaged building, is
exceptionally potent in increasing the produc-
tion of the inflammatory mediators tumor
necrosis factor α (TNFα), interleukin-6 (IL-
6), and nitric oxide in mouse macrophages in
vitro (Huttunen et al. 2000). IL-6 and TNFα
are proinflammatory cytokines and endoge-
nous pyrogens (Janeway and Travers 1997),
and NO is an important immunologic com-
ponent of host defense as well (Clancy and
Abramson 1995; Hibbs et al. 1987; Jorens et
al. 1993; Moncada et al. 1991). NO possesses
microbicidal activity and participates in non-
speciﬁc immune responses (Jorens et al. 1993),
but excessive NO production is involved in
several pathologic conditions, such as asthma
(Barnes and Kharitonov 1997) and some
autoimmune diseases (Kolb and Kolb-
Bachofen 1992). Macrophages and epithelial
cells in lungs are able to produce large amounts
of NO via inducible NO synthase (iNOS)
after presentation of an appropriate stimulus
(Asano et al. 1994; Moncada et al. 1991).
To study the pulmonary effects of M.
terrae, isolated originally from indoor air of a
moisture-damaged building, we instilled the
bacteria as a single intratracheal dose into
mouse lungs. Both the time course and the
dose response in inﬂammatory and cytotoxi-
city markers were evaluated.
Materials and Methods
Exposures. M. terrae was recovered from the
indoor air of a moldy building during demo-
lition work (Rautiala et al. 1996). The iso-
late, encoded as BA26 in our previous in
vitro studies (Huttunen et al. 2000), was
identified by gas liquid chromatography of
the fatty acids, fatty alcohols, and mycolic
acid cleavage products and by its growth and
biochemical characteristics. Moreover, the
result was negative when the isolate was
tested with a commercial DNA probe spe-
cific for Mycobacterium avium complex
(AccuProbe; Gen-Probe Inc., San Diego,
CA, USA), as described previously (Torkko
et al. 1998). The microbe was cultured on
Mycobacteria 7H11 agar supplemented with
oleic acid-albumin-dextrose-catalase enrich-
ment (Difco Laboratories, Detroit, MI,
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Occupants in moisture-damaged buildings suffer frequently from respiratory symptoms. This may
be partly due to the presence of abnormal microbial growth or the altered microbial ﬂora in the
damaged buildings. However, the specific effects of the microbes on respiratory health and the
way they provoke clinical manifestations are poorly understood. In the present study, we exposed
mice via intratracheal instillation to a single dose of Mycobacterium terrae isolated from the indoor
air of a moisture-damaged building (1 × 107, 5 × 107, or 1 × 108 microbes). Inflammation and
toxicity in lungs were evaluated 2 hr later. The time course of the effects was assessed with the
dose of 1 × 108 bacterial cells for up to 28 days. M. terrae caused a sustained biphasic inﬂamma-
tion in mouse lungs. The characteristic features for the first phase, which lasted from 6 hr to 3
days, were elevated proinflammatory cytokine [i.e., tumor necrosis factor α (TNFα) and inter-
leukin-6 (IL-6)] levels in the bronchoalveolar lavage fluid (BALF). TNFα was produced in the
lungs more intensively than was IL-6. Neutrophils were the most abundant cells in the airways
during the first phase, although their numbers in BALF remained elevated up to 21 days. The
characteristics of the second phase, which lasted from 7 to 28 days, were elevated TNFα levels in
BALF, expression of inducible nitric oxide synthase in BAL cells, and recruitment of mononuclear
cells such as lymphocytes and macrophages into the airways. Moreover, total protein, albumin,
and lactate dehydrogenase concentrations were elevated in both phases in BALF. The bacteria
were detected in lungs up to 28 days. In summary, these observations indicate that M. terrae is
capable of provoking a sustained, biphasic inﬂammation in mouse lungs and can cause a moderate
degree of cytotoxicity. Thus, M. terrae can be considered a species with potential to adversely
affect the health of the occupants of moisture-damaged buildings. Key words: bronchoalveolar
lavage, cytokines, inflammation, intratracheal instillation, lung, moisture-damaged building,
Mycobacterium terrae, nitric oxide. Environ Health Perspect 110:1119–1125 (2002). [Online
19 September 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1119-1125jussila/abstract.htmlUSA) at 30°C for 5 weeks. Then the bacterial
cells were washed, suspended in Hank’s bal-
anced salt solution (HBSS) (Gibco, Paisley,
UK), and sonicated in a water bath (Ultrasonic,
Lahti, Finland) for 15 min. The microbe con-
centration was counted with an epiﬂuorescence
microscope by using the acridine orange stain-
ing method adjusted for mycobacteria (Hobbie
et al. 1977; Katila and Mäntyjärvi 1982).
Before dosing, the cell suspension was sonicated
in a water-bath sonicator on ice for 40 min to
ensure a single cell suspension.
Animals. Specific pathogen-free male
NIH/S mice (8–9 weeks old) were obtained
from the breeding colony of the National
Public Health Institute, Division of
Environmental Health (Kuopio, Finland).
They were transferred from the barrier unit to
a conventional animal room and housed
singly in metal cages on aspen wood chips
(FinnTapvei, Kaavi, Finland) 1 week before
the experiment. Animals received water and
food (R36 Maintenance Diet for rats and
mice, Lactamin, Stockholm, Sweden) ad libi-
tum. The mice were on a 12-hr light/dark
cycle (lights on 700 hr–1900 hr) at 21°C and
27–38% relative humidity. The experimental
protocols were approved by the Research
Animal Committee of the University of
Kuopio and the Provincial State Ofﬁce.
Experimental design. The dose depen-
dence of the effects induced by the microbe
was investigated by exposing mice (10 ani-
mals/group) to a single dose of M. terrae (1 ×
107, 5 × 107, or 1 × 108 microbes/animal) or
HBSS (carrier control; Gibco) for 24 hr by
intratracheal instillation (50 µL/animal)
under 6% sevoflurane (Sevorane; Abbot,
Abbott Park, IL, USA) anesthesia. The time
course of the effects was studied at 6 and 24
hr and at 3, 7, 14, 21, and 28 days after the
exposure (10 animals/group) to a single dose
of 1 × 108 cells of M. terrae or HBSS.
Exposure to microbes. The bacteria were
instilled into mouse lungs as described previ-
ously (Jussila et al. 2001). In brief, an anes-
thetized mouse was laid in a 66° upward posture
and the incisors were placed on a wire. The dos-
ing was performed under visual control by using
a cold-light source (KL 1500 electronic; Schott,
Mainz, Germany) placed against the throat.
The nostrils were blocked, the tongue was
extended, and the dose was delivered onto the
vocal folds with a Finn pipette tip.
Sample collection. At the indicated expo-
sure times, the mice were anesthetized with
pentobarbital (100 mg/kg) and exsanguinated
by cardiac puncture. Blood was collected and
serum separated (Capiject T-MG; Terumo,
Elkton, MD, USA) for cytokine analyses.
Lungs (filled with 10% phosphate-buffered
formalin), liver, spleen, and lymph nodes
(mediastinal, axillary, brachial, and both
superficial and deep cervical nodes) of three
or four mice of each group were preserved in
10% phosphate-buffered formalin for
histopathologic evaluation. The tracheas of
the remaining animals (six or seven per
group) were cannulated with polyethylene
tubing. At ﬁrst, lungs were lavaged with two
portions of sterile HBSS (without Ca2+ and
Mg2+, containing 10 mM D-glucose, 37°C,
30 mL/kg), three times with each, and these
two portions were combined. Thereafter, to
obtain a greater number of cells, the lungs
were further lavaged with six portions of
HBSS as before, and these portions were
combined together. Lavage ﬂuids of these two
sets were kept on ice. Cytospin was per-
formed with the ﬁrst set of lavages (200 µL,
500 rpm for 10 min; Megafuge; Heraus
Instruments, Hanau, Germany). Slides were
fixed in methanol and stained with May-
Grünwald–Giemsa dye. Depending on the
number of cells on the slide, 16 or 24 fields
were counted to define the cell differentials.
Cells were separated from the ﬁrst two lavages
by centrifugation (540 × g for 8 min), and
the supernatant was centrifuged once more
(13,700 × g for 6 min at 4°C) to discard all
red blood cells and cell debris. Lactate dehy-
drogenase (LDH) concentrations were ana-
lyzed in fresh supernatants. The rest of the
supernatants were frozen (–80°C) for analyses
of TNFα, IL-6, albumin, and total protein.
Cells of the first two lavages were resus-
pended in 200 µL HBSS (without Ca2+ and
Mg2+, containing 10 mM D-glucose), and the
total cell number of each sample [cells per
milliliter bronchoalveolar lavage ﬂuid (BALF)]
was counted by the Trypan blue exclusion
method. The rest of the cell suspension was
centrifuged (540 × g for 8 min), and after dis-
carding the media, red blood cells were
hemolyzed from the cell pellet by hypotonic
shock. The cells were incubated for 30 sec
with 0.2% NaCl solution, and the suspension
was adjusted to be isotonic. After centrifuga-
tion (540 × g for 8 min), supernatant samples
were collected for hemoglobin assay. Cells of
the other set of lavages were centrifuged (540
× g for 8 min at 4°C), the buffer discarded,
and red blood cells hemolyzed as described
above. The cells were combined with the sur-
plus cells from the ﬁrst set of lavages, pelleted
(540 × g for 8 min at 4°C), and frozen for
later Western blot analyses of iNOS.
Analysis of IL-6 and TNFα. Cytokines
were analyzed from BALF and serum using the
enzyme-linked immunosorbent assay (ELISA)
method. Antibody pairs were obtained from
R&D Systems (Minneapolis, MN, USA), and
analyses were performed according to the man-
ufacturer’s instructions. The concentrations of
monoclonal capture antibody were 1 µg/mL
phosphate-buffered saline (PBS) for IL-6 and
0.8 µg/mL PBS for TNFα; concentrations of
biotinylated second antibody were 0.2 µg/mL
for IL-6 and 0.3 µg/mL for TNFα. We used
96-well microtiter plates (Maxisorb; Nunc,
Naperville, IL, USA). The standards were
diluted in diluent [0.1% bovine serum albu-
min (BSA), 0.05% Tween-20 in Tris-buffered
saline, pH 7.3 (20 mM Trizma base, 150 mM
NaCl)] for the analyses of BALF samples, and
in NIH/S mouse serum collected from animals
of our stock for serum analyses. Horseradish
peroxidase (HRP)-conjugated streptavidin was
used as a concentration of 1:200. Tetramethyl
benzidine (TMB) substrate solution (TMB
Single Solution; Zymed, San Francisco, CA,
USA) was incubated with samples and stan-
dards for 20 min. The absorbances were mea-
sured by ELISA reader (iEMS Reader MF;
Labsystems, Helsinki, Finland) at the wave-
length of 450 nm.
Analysis of LDH, total protein, albumin,
and hemoglobin. We analyzed the LDH con-
centration in BALF using the Cytotoxicity
Detection Kit (Boehringer Mannheim,
GmbH, Mannheim, Germany) with minor
modifications. Briefly, standards and BALF
samples (diluted 1:4 to lavage buffer) were
pipetted to 96-well MicroWell plates (Nunc,
Roskilde, Denmark) in duplicate, and the
mixture of the catalyst and the dye solution
was added into the wells. Reactions were ter-
minated by addition of stop solution (1 M
HCl) after 25-min incubation in the dark.
The absorbances were measured by ELISA
reader at the wavelength of 492 nm.
Total protein concentration in BALF
was determined by using the modified
Lowry method, DC Protein Assay (Bio-Rad,
Hercules, CA, USA). The BSA standards
(diluted to lavage buffer; Sigma, St. Louis,
MO, USA) and BALF samples were pipetted
to MicroWell plates in duplicate. An alka-
line copper tartrate solution and a dilute
Folin reagent were added, the plate was
mixed, and after 15 min of incubation, the
absorbances were measured by ELISA reader
at the wavelength of 690 nm.
The albumin concentration in BALF was
analyzed by using the ELISA method.
Antibody pairs were obtained from Bethyl
Laboratories (Montgomery, TX, USA), and
analyses were done according to the manufac-
turer’s instructions. The concentration of the
monoclonal capture antibody was 10 µg/mL
coating buffer (0.05 M sodium carbonate,
pH 9.6), and HRP-conjugated second anti-
body was diluted 1:80,000 in diluent [1%
BSA, 50 mM Tris (pH 8.0), 0.15 M NaCl,
0.05% Tween-20]. We used Maxisorb 96-
well microtiter plates (Nunc). BALF samples
(1:900) and the standards were diluted in
diluent. TMB substrate solution (TMB
Single Solution) was incubated with samples
and standards for 4 min. The absorbances
were measured by ELISA reader (iEMS
Reader MF) at the wavelength of 450 nm.
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natants of hemolyzed cell pellets were ana-
lyzed by using the modified Stadie method
(Procedure No. 525; Sigma). Brieﬂy, 250 µL
Drabkin’s reagent and human methemoglo-
bin standards (diluted to Drabkin’s reagent)
were pipetted to MicroWell plates in dupli-
cate, and 10-µL samples were added to the
wells in duplicate. After mixing and 15 min of
incubation, the absorbances were measured by
ELISA reader at the wavelength of 540 nm.
Hemoglobin concentrations are expressed as
micrograms per milliliter BALF.
Western blot analysis of iNOS. Cells were
lysed in lysis buffer [20 mM Tris HCl (pH
8.0), 2 mM EDTA, 3% Triton X-100, 100
mM NaCl, 1 mM Na3VO4, 10 µg/mL apro-
tinin, 10 mg/mL leupeptin, 1 mM phenyl
methyl sulfonyl fluoride] using a 26-gauge
needle and a syringe (1 mL). We added 4 ×
sample buffer [124 mM Tris HCl (pH 6.8),
140 mM sodium dodecyl sulfate (SDS), 2,700
mM glycerol (20%), 0.3 mM bromophenol
blue, 100 mM mercaptoethanol] 1:4 and then
heated the samples to 95°C for 7 min. When
cells were lysed, the samples (> 53 µg protein)
and markers (Bio-Rad) were subjected to elec-
trophoresis [7.5% Tris HCl gels (Criterion,
Bio-Rad); running buffer: 25 mM Tris, 190
mM glycine, 0.1% SDS; 150 V for 50 min].
Proteins were transferred electrophoretically to
a PVDF membrane (Immun-Blot, Bio-Rad;
transfer buffer: 25 mM Tris, 190 mM glycine,
20% methanol, 0.05% SDS; 100 V for 1 hr).
After blocking with 5% BSA (Sigma), the
membranes were incubated in primary anti-
body solution [0.1% rabbit anti-iNOS
polyclonal antibody (BD Transduction
Laboratories, Lexington, KY, USA) in 5%
BSA] for 1 hr. After 6 × 5 min washings in
washing buffer (10 mM Tris, 100 mM NaCl,
0.1% Tween-20; pH 7.5), the membranes
were incubated in alkaline phosphatase (AP)-
conjugated second antibody solution [0.1%
AP-goat anti-rabbit immunoglobulin G
(Zymax, Zymed) in 5% BSA] for 1 hr. The
membranes were washed six more times and
exposed to AP developing buffer (100 mM
NaCl, 100 mM Tris base and 5 mM MgCl)
for 1 min. Finally, the membranes were devel-
oped using BCIP/NBT (330 µg/mL nitro
blue tetrazolium, 165 µg/mL bromochloroin-
dolyl phosphate disodium) in developing
buffer, and the reaction was stopped by rins-
ing the membranes in tap water.
Analysis of histopathologic changes and
mycobacterial inﬁltration. Tissue samples from
lungs, lymph nodes, spleen, and liver of three
or four nonlavaged mice from each group were
fixed and stored in 10% buffered formalin.
Samples were then trimmed, dehydrated,
embedded in parafﬁn, cut into 5-µm sections,
and stained with standard hematoxylin and
eosin. We used a light microscope to evaluate
histopathologic changes. To evaluate inﬁltra-
tion of M. terrae especially in lungs, sections
including left lung and spleen tissue from
three animals in each group in the time-
course experiment were stained with standard
Ziehl-Neelsen or auramine-rhodamine.
Infiltration was subjectively graded as none,
scattered, moderate, strong, or very strong
from Ziehl-Neelsen–stained sections under a
light microscope, and identification of the
mycobacteria from the slides was confirmed
from auramine-rhodamine-stained sections
under a ﬂuorescence microscope. The clearly
strongest occurrence of the mycobacterial
cells observed in this study was graded as very
strong. Scattered inﬁltration was indicated by
slight, dispersed mycobacterial cell occurrence
in the alveolar macrophages or other cells.
Samples between these two grades were
divided into two more grades, moderate and
strong, according to the occurrence of the
mycobacterial cells in the lungs.
Statistical analysis. In the dose–response
experiment, we analyzed the normally distrib-
uted data with equal variances between groups
using analysis of variance and Dunnett’s test:
exposed groups were compared with the car-
rier control group. Otherwise, we performed
Kruskall-Wallis (SPSS, version 7.5.1; SPSS
Inc., Chicago, IL, USA) and Dunn’s tests (Zar
1996). In the time-course experiment, we
analyzed biochemical data at each time point
using the two-tailed Mann-Whitney U-test
(SPSS, version 7.5.1). The difference was
considered signiﬁcant at p < 0.05.
Results
Production of proinﬂammatory cytokines. To
evaluate the ability of M. terrae to induce
proinflammatory cytokine production in
mouse lungs, we measured the concentrations
of TNFα and IL-6 in BALF. In the dose–
response experiment, neither the TNFα nor
IL-6 concentrations changed statistically sig-
niﬁcantly, although the IL-6 level was almost
3-fold with the highest dose (1 × 108 cells)
when compared with carrier controls at 24 hr
after the instillation (Table 1).
The time course of these cytokines in
BALF indicated that the peak concentrations
had been attained earlier than 24 hr after the
instillation (Figure 1). Six hours after 
the instillation, M. terrae (1 × 108 cells)
increased TNFα concentration by 10-fold.
The TNFα level had decreased very steeply
by 24 hr, but it remained significantly ele-
vated up to 14 days and 40% above the con-
trol values on days 21 and 28 after the
instillation (p = 0.055 at both time points).
The IL-6 concentration in BALF was five
times higher in the M. terrae group than in
the control group at 6 hr, and 3-fold higher
at 24 hr, but it had leveled off by 7 days after
the instillation.
To evaluate the possibility that the M.
terrae exposure in lungs might also affect sys-
temic cytokine levels, we analyzed TNFα and
IL-6 concentrations in serum. At these doses,
M. terrae did not alter the cytokine concen-
trations compared with controls (data not
shown). The cytokine levels were mostly
below the detection limit.
Expression of iNOS. Instillation of M.
terrae induced the expression of NO-produc-
ing iNOS protein in BAL cells. The protein
was detectable from 7 to 28 days after the
instillation of the bacterium (Figure 2).
Cells in BALF. The cell proﬁle and num-
bers in alveoli and BALF reﬂected the process
in lungs induced by M. terrae. As shown in
Figure 3A, only the highest dose of the bacte-
rial cells increased the total cell number in
BALF by 75% at 24 hr after the instillation,
even though the increase was not statistically
significant. A similar pattern was evident in
macrophages and neutrophils in BALF. The
lymphocyte and eosinophil numbers did not
change at 24 hr.
Interestingly, the time course of the cellu-
lar response seemed to consist of two phases
in M. terrae-treated animals. The total cell
Articles • M. terrae induces sustained inflammatory response
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Table 1. Components of BALF 24 hr after instillation of the graded doses of M. terrae.
TNFα IL-6 Albumin Total protein LDH Hemoglobin
(pg/mL) (pg/mL) (µg/mL) (µg/mL) (mU/mL) (µg/mL)
Carrier control 40 ± 9 7 ± 1 145 ± 21 176 ± 41 179 ± 29 26 ± 18
M. terrae 1 × 107 56 ± 26 9 ± 3 185 ± 27 173 ± 32 215 ± 50 7 ± 5
M. terrae 5 × 107 36 ± 5 8 ± 1 168 ± 20 149 ± 08 237 ± 53 ND
M. terrae 1 × 108 59 ± 12 21 ± 8 220 ± 67 217 ± 41 322 ± 53 37 ± 14
ND, not detected. Values shown are mean ± SE of six or seven animals per group.
Figure 1. Concentrations of TNFα and IL-6 in BALF
at seven different time points after the instillation of
M. terrae (1 × 108; n = 5–6). Abbreviations: cc, car-
rier control; Mt, M. terrae. HBSS was used as the
carrier control. Each point represents mean ± SE. 
*Statistically signiﬁcantly different from the carrier control
(p < 0.05). 
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*number in BALF was increased at 6 hr,
reached the maximum at 24 hr after the instil-
lation of M. terrae (Figure 3B), and decreased
by 7 days. The increase in the total cell num-
ber in this phase was mainly due to neu-
trophils (Figure 3B,C). Thereafter, the total
cell number increased again, to a constant
level that was approximately four times higher
than in the control group. The neutrophil
concentration was signiﬁcantly increased at 6
hr, reached the highest level at 24 hr, but
decreased slowly to near the control level by
28 days. Macrophages and lymphocytes were
predominantly responsible for the increased
total cell concentration at the second phase of
the cellular response. The number of lympho-
cytes and macrophages increased signiﬁcantly
in BALF from day 7 to the end of the experi-
ment (Figure 3C). Eosinophils were not
observed in BALF in either experiment.
Red blood cells in BALF may indicate
increased epithelial permeability and/or tissue
damage. M. terrae did not increase the hemo-
globin concentration in BALF in a statisti-
cally signiﬁcant manner (Table 1).
Albumin, total protein, and LDH.
Vascular leakage and cytotoxicity were
assessed further by measuring albumin, total
protein, and LDH concentrations from
BALF. The mean albumin concentration in
BALF was increased slightly by all doses of
M. terrae at 24 hr, most notably with the
highest dose (Table 1). The data from the
time-course experiment indicated that the
albumin level remained elevated up to 28
days after the instillation of the bacteria
(Figure 4A). The highest albumin levels were
detected at 14 and 21 days after the dosing.
Only the highest dose of M. terrae
increased total protein in BALF. This effect
was more evident in the time-course experi-
ment (Figure 4B), for which the total protein
level was increased throughout the experiment.
The highest level was reached on day 14. The
LDH concentrations in BALF were above the
control level up to 28 days during the expo-
sure to the highest dose of M. terrae (Table 1,
Figure 4C).
Interestingly, albumin, total protein, and
LDH responses all displayed the similar two-
peak pattern as the total cell number: the ﬁrst
increase was detected before 7 days, and the
second was observable from 14 days onward.
The responses were present throughout the
experiment (up to 28 days).
Histopathologic changes in lungs and
clearance of the mycobacterium from the
lungs. At necropsy, hyperemia was seen in
lungs from 7 to 21 days after the instillation
of M. terrae (1 × 108). The frequency of ani-
mals with hyperemia and severity of the
change increased up to 3 weeks. Moreover,
lungs appeared patchy and edemic, especially
at 14 and 21 days. Macroscopic changes had
almost disappeared by 28 days.
In histopathology, a slight focal increase in
neutrophils was observed in alveoli and partly
in bronchiolar lumen 6 hr after the instillation
of 1 × 108 mycobacterial cells. Neutrophils
increased focally in a dose-dependent manner.
Also, several larger neutrophil-rich areas were
Articles • Jussila et al.
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Figure 3. Inﬂammatory cells in BALF at (A) 24 hr after the instillation of the graded doses of M. terrae (1 × 107, 5 × 107, and 1 × 108; n = 6–7 animals) and at (B and C)
seven different time points after the instillation of the bacterial cells (1 × 108; n = 3–6). Abbreviations: cc, carrier control; Mt, M. terrae. Values shown are mean ± SE. 
*Statistically signiﬁcantly different from the carrier control (p < 0.05). 
Figure 4. (A) Albumin, (B) total protein, and (C) LDH concentrations in BALF at seven different time points after the instillation of M. terrae (1 × 108; n = 5–6).
Abbreviations: cc, carrier control; Mt, M. terrae. Values shown indicate mean ± SE.
*Statistically signiﬁcantly different from the carrier control (p < 0.05).
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Figure 2. Western blot for iNOS in cells obtained by
BAL from mouse lungs at indicated times after the
instillation of 1 × 108 bacteria. Abbreviations: cc,
carrier control; pc, positive control; Mt, M. terrae.
More than 53 µg of protein was loaded in each
lane. Lane 1, marker; lane 2, cc 3 days; lane 3, Mt 7
days; lane 4, cc 7 days; lane 5, Mt 14 days; lane 6,
cc 14 days; lane 7, Mt 21 days; lane 8, cc 21 days;
lane 9, Mt 28 days; lane 10, cc 28 days; lane 11, pc.
1
Marker
(123 kDa)
23456789 1 0 1 1
iNOS
(130 kDa)seen in the lungs at 24 hr (Figure 5).
Macrophages and other mononuclear cells
were increasingly present in alveolar and partly
in bronchiolar spaces at 3 days, and their
occurrence in alveoli was increased up to 28
days. Mononuclear cells such as lymphocytes
and macrophages were typically seen perivas-
cularly and peribronchiolarly; even large
lesions were frequently observed, especially at
days 14 and 21. Histopathologic ﬁndings cor-
related well with the cell profiles of BALF.
Moreover, a reactive hyperplastic change was
observed in lymph nodes associated with lungs
from 14 to 28 days. Spleens and livers seemed
to be normal in the microscopic examination.
Mycobacterial cells were present in the
lungs throughout the experiment, even on
day 28 (Figures 5, 6). The numbers seemed
to be highest at 24 hr (Figure 6), which was
presumably due to the fact that all of the
mycobacteria were not phagocytized at 6 hr,
and they might have been partly lost during
the processing of the samples. The elimina-
tion phase seemed to begin after 14 days.
Discussion
Our results show that a single dose of M.
terrae, originally isolated from a moisture-dam-
aged building, can induce a sustained, biphasic
inﬂammation in mouse lungs, which lasts at
least for 28 days. This effect was veriﬁed both
biochemically in BALF and histopathologi-
cally. The present data demonstrate that M.
terrae can cause a prolonged inﬂammation in
the lungs, and via that pathway it may affect
health, even though it can rarely cause severe
mycobacterial diseases in humans (Peters and
Morice 1991; Spence and Ferris 1996).
Production of proinﬂammatory cytokines
(i.e., TNFα and IL-6) was increased in mouse
lungs in a time-dependent manner after expo-
sure to M. terrae. This is consistent with our
recent in vitro ﬁndings demonstrating that M.
terrae induces dose- and time-dependent
increases in TNFα and IL-6 production in
mouse RAW264.7 macrophages in vitro
(Huttunen et al. 2000, 2001). The acute
phase of TNFα production was over by 24 hr,
but increased TNFα production in lungs was
evident for up to 2 weeks. Mycobacteria con-
tain several components, such as different
types of cell envelope glycolipid lipoarabino-
mannans (LAMs), which can increase TNFα
production (Chatterjee and Khoo 1998;
Marshall et al. 1997). This is of interest
because TNFα plays an important role in both
protective and pathologic immune responses
against mycobacterial infections (Marshall et al.
1997). IL-6 production in mouse lungs
induced by M. terrae was more transient and
weaker than was TNFα production. This effect
is in line with our in vitro ﬁndings with mouse
RAW264.7 macrophages (Huttunen et al.
2001). The correlation between the in vitro and
in vivo data for M. terrae supports the view that
macrophages are involved in the production of
these proinﬂammatory mediators in the lungs.
In addition, neutrophils and lymphocytes are
commonly known sources of these cytokines
(Barnes et al. 1998; Jablonska et al. 1999).
TNFα is classically considered to be one of
the mediators triggering NO production via
iNOS (Cunha et al. 1994), and nitrogen radi-
cals have been suggested to be essential in
depletion of intracellular mycobacteria (Denis
1991; Flesch and Kaufmann 1991). Different
mycobacterial strains possess varying abilities
to affect TNFα and NO synthesis. For exam-
ple, the two mycobacterial species M. smegma-
tis and M. vaccae have been shown to increase
TNFα production of mouse macrophages
more than does Mycobacterium bovis bacillus
Calmette-Guérin (BCG) in vitro (Marshall et
al. 1997). The strains causing higher TNFα
production did not apparently induce NO
production, in contrast to M. bovis BCG. In
the present study, M. terrae caused an acute
and high TNFα production in mouse lungs.
However, iNOS expression was not detected
until after 7 days, although the induction of
the expression of iNOS can occur within a few
hours. Hence, M. terrae may induce expression
of iNOS in mouse lungs via a TNFα-indepen-
dent pathway, or high TNFα may even sup-
press the induction of iNOS expression during
the infection. In our recent in vitro study, the
exact same strain of M. terrae induced iNOS
expression in mouse RAW264.7 macrophages
at 24 hr (Huttunen et al. 2001). However,
the regulation of the iNOS expression in vivo
may be more complex than in vitro. Inducible
NOS response was sustained because the pro-
tein was detected from lavaged cells up to 28
days. So far, it is not known which cells were
responsible for the iNOS expression in the
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Figure 5. Histopathologic appearance of mouse lungs at different time points after the instillation of M. terrae (1 × 108 bacterial cells). Abbreviations: al, alveolar
structures; br, bronchiole; v, blood vessel. (A) Carrier control-exposed lungs 6 hr after instillation; intact alveolar structures (al), a blood vessel (v), and part of a
bronchiole (br) are shown. (B) M. terrae-exposed lungs 6 hr after instillation; alveolar structures are visible with a few mycobacterium-infected alveolar
macrophages (some of them indicated by arrows; the mycobacteria were stained red). (C) Intense neutrophil response was observed 24 hr after M. terrae instilla-
tion; neutrophil inﬁltrations are clearly visible near or inside the bronchioles (br; lower arrows), and a large neutrophil-rich area is visible in upper part of the photo-
graph (upper arrows). Phagocytized mycobacterial cells were most abundantly seen at this time point (D and E). Perivascular mononuclear cell inﬁltrations near the
infected cells (arrows) in alveolar spaces are visible 3 days (D) and 7 days (E) after the instillation. (F) Large peribronchiolar and perivascular mononuclear cell inﬁl-
trations with granuloma-like structure (arrow) are apparent at 14 days. (G and H) Peribronchiolitis and perivasculitis are visible also 21 days (G) and 28 days (H)
after dosing. Moreover, granulomas with the mycobacteria inside (arrows) are apparent at both late time points. The mycobacterial cells are visible throughout the
lesion (H). Arrows indicate some of the mycobacteria-infected cells. Scale bars in A–G = 50 µm; scale bar in H = 10 µm.lavaged cells and, accordingly, to what extent
it reflects changes in cell populations over
time. The data suggest that NO production
was increased in the lungs at the later phase of
the inﬂammatory response. This is of special
interest because high levels of NO, produced
by iNOS, may cause vasodilatation, edema,
and cytotoxicity (Barnes et al. 1998; Clancy
and Abramson 1995). For example, NO is
thought to be an important factor in acute
lung injury induced by the bacterial endo-
toxin lipopolysaccharide (Kristof et al. 1998).
A similar time frame for NO production has
also been detected during M. bovis BCG
exposure, which induced NO synthesis in
mouse pleural cells, presumably via iNOS at
1 and 2 weeks after intrathoracic injection
(Moura et al. 1999).
In this study, M. terrae caused transient
IL-6 production in mouse lungs. IL-6 has
been reported to be involved in lymphocyte
activation, growth, and differentiation; to
increase secretion of immunoglobulins; and
to be one factor that can initiate an acute
phase response (Barnes et al. 1998; Van Snick
1990). TNFα can also induce IL-6 produc-
tion in some circumstances (VanHeyningen
et al. 1997). Moreover, mycobacterial LAM
can also increase the production of IL-6
(Chatterjee and Khoo 1998). The role of IL-6
is not clear in mycobacterial infections. It has
been suggested to decrease mycobacterial
growth at low levels and increase it at higher
levels (VanHeyningen et al. 1997). Even
though IL-6 seems to be crucial for control-
ling intracellular infections, constitutive
release of this cytokine is able to impair the
ability of macrophages to induce T-cell stim-
ulation (Kopf et al. 1994; VanHeyningen et
al. 1997). T-cell–mediated immunity is
essential in the host defense against mycobac-
terial diseases (Holland 1996). 
TNFα and NO have been shown to be
important mediators in recruiting neutrophils
into thoracic cavity of the mouse during M.
bovis BCG exposure (Menezes-de-Lima et al.
1997) and might contribute to attracting
neutrophils into the airways also during the
M. terrae exposure. In this study, inﬂamma-
tory cell response seemed to consist of two
phases. In the first phase, neutrophils repre-
sented over 60% of the lavaged cells, the rest
being mainly macrophages. This phase was
distinct at 24 hr, veriﬁed also in histopathol-
ogy, and represents an acute inﬂammation in
lungs. Mononuclear cells, such as lymphocytes
and macrophages, constituted the second
phase, chronic inﬂammation, manifested from
14 days onward, this being observed both in
lavaged cells and with histopathologic analysis.
A biphasic cellular response was also observed
after intrathoracic injection of M. bovis BCG
in C57Bl/6 mouse (Menezes-de-Lima et al.
1997). The sustained increase in alveolar
macrophages caused by M. terrae may be due
to the observed slow clearance of the mycobac-
teria in the lungs and subsequent attraction of
macrophages by the microbial cells as long as
they exist in the bronchiolar and alveolar
spaces. Scattered mycobacteria were seen in the
lungs even at the end of the surveillance period
to maintain the cell response as well as the bio-
chemical changes.
The rapid neutrophil response has been
shown to control fast-growing intracellular
bacteria such as Listeria monocytogenes and
Salmonella typhimurium but not slow-grow-
ing Mycobacterium tuberculosis or M. bovis
BCG in intravenously infected mice (Seiler et
al. 2000). Even though neutrophils may not
be crucial for defending against invading M.
terrae, the sustained neutrophil response
observed in this study suggests that they par-
ticipate in controlling the slow-growing M.
terrae infection in mouse lungs, when mice
have been exposed via their airways. In a sim-
ilar manner, neutrophils have been reported
to play a role also in controlling slow-growing
M. bovis BCG lung infection in mice when
bacteria were delivered by intratracheal instil-
lation (Fulton et al. 2000). Neutrophils can
produce chemokines and other inﬂammatory
mediators that enhance accumulation of
monocytes into infected lung areas (Cassatella
1995), and at least human neutrophils have
been reported to be able to phagocytose and
kill slow-growing mycobacteria (Jones et al.
1990). However, M. terrae caused faster
increase in neutrophils, and the response set-
tled down earlier than during M. bovis BCG
exposure. Moreover, the route of exposure
may be an important factor when inﬂamma-
tory responses of lungs are evaluated.
Acute pulmonary inﬂammation is known
to increase epithelial permeability, which
increases albumin and other protein influx
into alveolar spaces (Li et al. 1995, 1999). In
concordance with this, in this study both
albumin and total protein increased tran-
siently in BALF, after the cell inﬂuxes during
M. terrae infection. The biphasic nature of
inﬂammatory responses induced by M. terrae
was seen also in these parameters. The sus-
tained increase of vascular leakage from 7
days up to the end of this study (28 days)
was apparent. Because hemoglobin in BALF
did not increase, erythrocytes did not exces-
sively ﬂow into alveolar spaces; that is, capil-
lary destruction was not evident. Also, the
histopathology did not reveal any gross toxic-
ity besides inflammation-associated changes
in lungs. The sustained LDH response in
BALF might predominantly represent dying
inﬂammatory cells in the lungs during a pro-
longed inﬂammatory process.
In the case of particles, overloading of alve-
olar macrophages is a phenomenon that may
cause nonspeciﬁc inﬂammatory responses, even
though the mouse may not be a particularly
sensitive species in this respect (Donaldson
2000; Morrow 1992). Previously we used this
mouse model to study the inflammatory
responses induced by the spores of Streptomyces
californicus, a gram-positive bacterium fre-
quently isolated from moisture-damaged
buildings (Jussila et al. 2001). Both the spores
of S. californicus and bacterial cells of M. terrae
are spherical particles, and their diameters are
approximately the same size (~1 µm).
Volumetric particle loads of the doses in the
present study were below the suspected dose
level which can cause nonspecific responses
due to overloading of the alveolar macrophages
when calculated as described previously (Jussila
et al. 2001). 
In summary, M. terrae, originally isolated
from indoor air of a moisture-damaged build-
ing, provoked a sustained, biphasic inﬂamma-
tory reaction in mouse lungs and caused
moderate cytotoxicity. The results suggest
that the first phase, acute inflammation, is
mediated via TNFα, and the second, chronic
phase, via NO produced by iNOS. The long-
lasting response can be explained by slow
eradication of the mycobacteria from the
mouse lungs. The bacteria were detectable at
least for 28 days after the dosing. Hence, M.
terrae may well be among the microbial
species causing respiratory symptoms and
other immunologic disturbances in the occu-
pants of moisture-damaged buildings. Even
short, intermittent exposures may suffice to
maintain the inﬂammation.
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